Suchergebnisse - "Hiller, Benjamin M"

PubPharm (6)

1

ENGINEERED NANOBODIES WITH PROGRAMMABLE TARGET ANTIGEN PROTEOLYSIS (PTAP) FUSIONS REGULATE INTRACELLULAR ALPHA-SYNUCLEIN IN VITRO AND IN VIVO

enthalten in: Research square | 2024

von Chatterjee, D. | D'Brant, L. | Hiller, B. | +7

2

Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease

enthalten in: NPJ Regenerative medicine | 2022

von Hiller, B. | Marmion, D. | Thompson, C. | +6

3

Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in vivo

enthalten in: Stem cells translational medicine | 2021

von Hiller, B. | Marmion, D. | Gross, R. | +6

4

Viral-based rodent and nonhuman primate models of multiple system atrophy : Fidelity to the human disease

enthalten in: Neurobiology of disease | 2021

von Marmion, D. | Rutkowski, A. | Chatterjee, D. | +7

5

Mitomycin‐C treatment during differentiation of induced pluripotent stem cell‐derived dopamine neurons reduces proliferation without compromising survival or function in vivo

enthalten in: Stem cells translational medicine | 2021

von Hiller, B. | Marmion, D. | Gross, R. | +6

6

Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo

enthalten in: Stem cell reports | 2017

von Wakeman, D. | Hiller, B. | Marmion, D. | +10

1
[1]